The Emergence of the Metabolic Syndrome with Menopause
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Women with the metabolic syndrome (central obesity, insulin resistance, and dyslipidemia) are known to be at especially high risk for cardiovascular disease (CVD). The prevalence of the metabolic syndrome increases with menopause and may partially explain the apparent acceleration in CVD after menopause. The transition from pre- to postmenopause is associated with the emergence of many features of the metabolic syndrome, including 1) increased central (intraabdominal) body fat; 2) a shift toward a more atherogenic lipid profile, with increased low density lipoprotein and triglycerides levels, reduced high density lipoprotein, and small, dense low density lipoprotein particles; 3) and increased glucose and insulin levels. The emergence of these risk factors may be a direct result of ovarian failure or, alternatively, an indirect result of the metabolic consequences of central fat redistribution with estrogen deficiency. It is unclear whether the transition to menopause increases CVD risk in all women or only those who develop features of the metabolic syndrome. This article will review the features of the metabolic syndrome that emerge with estrogen deficiency. A better understanding of these metabolic changes with menopause will aid in the recognition and treatment of women at risk for future CVD, leading to appropriate interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disturbances of this metabolic signal lead to the development of metabolic syndrome and a higher cardiovascular risk in women.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [31]
Citations
Cites
3 retracted
Changes in energy balance and body composition at menopause: a controlled longitudinal study.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00005 · Cited by 520 · cited 4×
“Several groups have shown increased fasting insulin (22, 48) and increased fasting glucose levels (37, 63) in postmenopausal compared with premenopausal women, which would imply worsened insulin resistance with the menopause.”
BackgroundInfluentialRetractedMenopause, energy expenditure, and body composition
Poehlman, E. T. (2002) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810705.x · Cited by 137 · cited 1×
“Menopause is also associated with reduced lean body mass (muscle) and this appears to be related to decreased physical activity (36).”
BackgroundRetractedPoehlman, É. T., Toth, M., Ades, P. A., & Rosen, C. J. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1160662.x · Cited by 128 · cited 4×
“sociated with weight gain, most studies do not reveal increases in BMI independent of normal aging (23, 24).”
BackgroundInfluentialRetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · cited 1×
“Although syndrome X was initially coined by Gerald Reaven in 1988 (16), the features of the metabolic syndrome were first described by Vague (17) and have subsequently been called the insulin resistance syndrome, the central obesity syndrome, and the deadly quartet.”
BackgroundThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033 · cited 1×
“The metabolic syndrome may not be a single disease entity, but, rather, a constellation of closely related risk factors that together convey substantially increased cardiovascular risk after accounting for traditional CVD risk factors (12).”
BackgroundPark, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074 · cited 3×
“The metabolic syndrome is estimated to affect approximately 20–30% of the middle-aged population (10), and prevalence appears to be increasing in the U.”
BackgroundInfluentialChambless, L. E., Heiss, G., Folsom, A. R., Rosamond, W., Szklo, M., Sharrett, A. R., & Clegg, L. X. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009302 · Cited by 1,990
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Cited by
Items 601–700 of 1,001
Macías-Cortés, E. D. C., Llanes-González, L., Aguilar-Faisal, L., & Asbún‐Bojalil, J. (2017) · Homeopathy · doi:10.1016/j.homp.2016.11.002 · Cited by 20
Obesity alters the ovarian glucidic homeostasis disrupting the reproductive outcome of female rats
Bazzano, M. V., Paz, D. A., & Elia, E. M. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.01.003 · Cited by 20
Sexual Dimorphism in the Selenocysteine Lyase Knockout Mouse
Ogawa-Wong, A. N., Hashimoto, A. C., Ha, H. Y., Pitts, M. W., Seale, L. A., & Berry, M. J. (2018) · Nutrients · doi:10.3390/nu10020159 · Cited by 19
“For instance, pre-menopausal women are protected from the impacts of a high fat diet on insulin resistance when compared to age-matched men, but these effects are abolished in menopausal women [14].”
BackgroundEffects of concurrent exercise on cardiometabolic status during perimenopause: the FLAMENCO Project
Coll‐Risco, I., Borges‐Cosic, M., Acosta‐Manzano, P., Camiletti‐Moirón, D., Aranda, P., & Aparicio, V. A. (2018) · Climacteric · doi:10.1080/13697137.2018.1526892 · Cited by 23
“Even so, as a healthy diet and increasing physical activity levels and exercise have proven beneficial effects, the research team undertook four conferences (one each month) addressing different topics: (1) benefits of exercise for longevity, prevention, and treatment of diseases; (2) benefits of the Mediterranean die…”
BackgroundPaulsen, S. K., Nielsen, M. P., Richelsen, B., Bruun, J. M., Flyvbjerg, A., & Pedersen, S. B. (2008) · Obesity · doi:10.1038/oby.2008.2 · Cited by 23
“incidence of hypertension (7), an aggravation of the lipoprotein profile (8), and a shift in body-fat distribution toward a more central or male-type distribution (10), leading to metabolic syndrome (11) and subsequently a rise in the incidence in cardiovascular disease (12).”
BackgroundDelgado, J. C. S., Hortúa, A. M. J., Uribe-Sarmiento, O. M., Philbois, S. V., Pereira, A. C., Rodrigues, K. P., & de Souza, H. C. D. (2023) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2023e12241 · Cited by 20
“In addition, menopause is associated with increased body weight, speci fi cally adipose tissue, often associated with insulin resistance, dyslipidemia, and increased cardiovascular and metabolic risks (3).”
BackgroundHyvärinen, M., Karvanen, J., Juppi, H., Karppinen, J. E., Tammelin, T., Kovanen, V., Aukee, P., Sipilä, S., Rantalainen, T., & Laakkonen, E. K. (2023) · Maturitas · doi:10.1016/j.maturitas.2023.05.004 · Cited by 22
Ho, I., Wong, C., Wong, Y., Lam, T.-H., Leung, I. S. H., Lin, M., Lui, D. T. W., Kwok, W. C., Tam, C. C., Chan, Y., et al. (2023) · JACC Asia · doi:10.1016/j.jacasi.2023.09.014 · Cited by 20
Cancer knocks you out by fasting: Cachexia as a consequence of metabolic alterations in cancer
Cortellino, S., D’Angelo, M., Quintiliani, M., & Giordano, A. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31417 · Cited by 20
“…such as tamoxifen and aromatase inhibitors, can increase the risk of metabolic and cardiovascular dysfunctions by lowering estrogen and androgen levels, potentially causing weight gain, diabetes, dyslipidemia, and nonalcoholic fatty liver disease (NAFLD) (Carr, 2003; Mauvais ‐ Jarvis, 2011).”
Neuropeptide Y mediates the short-term hypometabolic effect of estrogen deficiency in mice
Zengin, A., Nguyen, A., Wong, I. P. L., Zhang, L., Enriquez, R., Eisman, J. A., Herzog, H., Baldock, P., & Sainsbury, A. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.71 · Cited by 19
Minta, W., Palee, S., Mantor, D., Sutham, W., Jaiwongkam, T., Kerdphoo, S., Pratchayasakul, W., Kumfu, S., Chattipakorn, S. C., & Chattipakorn, N. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.01.006 · Cited by 19
“The prevalence of metabolic syndrome has been shown to increase in women with low levels of estrogen such as those post-menopausal women, and women who have undergone ovariectomy (Carr, 2003; Dorum et al., 2008).”
Amput, P., Palee, S., Arunsak, B., Pratchayasakul, W., Thonusin, C., Kerdphoo, S., Jaiwongkam, T., Chattipakorn, S. C., & Chattipakorn, N. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15556 · Cited by 18
Managing Cardiovascular Risk in Patients with Rheumatic Disease
Ferguson, L. D., Sattar, N. A., & McInnes, I. B. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2020.09.010 · Cited by 19
“Decreasing estrogen during the menopause also may have a detrimental effect on renal uric acid excretion(37) and contribute to increased central (abdominal) obesity associated with increased cardiometabolic risk.(38) Finally, it is possible clinicians may be less vigilant in prompt diagnosis and treatment of gout and…”
BackgroundKim, S., Choi, S.-Y., Lee, H., Ju Kim, J., & Eun Park, H. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63371 · Cited by 18
Ahlgren, C., Hammarström, A., Sandberg, S., Lindahl, B., Olsson, T., Larsson, C. L., & Fjellman‐Wiklund, A. (2015) · International Journal of Behavioral Medicine · doi:10.1007/s12529-015-9495-x · Cited by 22
“After menopause, women have increased risk of abdominal accumulation of fat associated with highly increased risk of metabolic dysfunction and cardiovascular disease [17].”
BackgroundRamírez-Salazar, M., Pérez-Luque, E. L., Fajardo-Araujo, M. E., Martínez-Garza, S., & Malacara, J. M. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31816d5b2d · Cited by 19
Obesity and metabolic syndrome during the menopause transition in Serbian women
Živković, T. B., Vuksanović, M., Andjelic‐Jelic, M., Stojanović, J., Buric, B., Jojić, B., Milic, N. M., & Vujović, S. (2011) · Climacteric · doi:10.3109/13697137.2011.569595 · Cited by 19
The Metabolic Syndrome in Women
Rosano, G. M. C., Vitale, C., & Mercuro, G. (2006) · Women s Health · doi:10.2217/17455057.2.6.889 · Cited by 20
“In postmenopausal women, the state of ovarian hormone deficiency induces metabolic and physiological changes that lead to a greater prevalence of hypertension and metabolic syndrome compared with the premenopausal period [9].”
BackgroundMetabolic correlates of menopause: an update
Ross, L. A., & Polotsky, A. J. (2012) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32835a91bc · Cited by 19
“During the menopausal transition, the incidence of MetS, but not T2DM, as an independent factor has been described to rise [1,18].”
BackgroundCheng, P., Lee, Y., Yen, M., Peng, J.-C., & Lam, K. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31820db576 · Cited by 20
“Postmenopausal women tend to gain body fat, which seems to be a consequence of the decline in endogenous estrogens.(11,12) In addition, ovariectomized (Ovx) rats develop obesity(13,14); hormone therapy in postmenopausal women or estrogen treatment of Ovx rats reduces the development of metabolic syndrome, particularly…”
BackgroundChedraui, P. A., Pérez-López, F. R., Blümel, J. E., Hidalgo, L., & Barriga, J. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903184092 · Cited by 20
Ortiz, A. P., Suarez, E. L., Beauchamp, G., Romaguera, J., Soto‐Salgado, M., & Pérez, C. M. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0076 · Cited by 20
“Menopausal status was defi ned as: (1) premenopause if menses had occurred in the past 12 months and (2) postmenopause if menses had stopped for at least 12 months without surgery (natural menopause) or as a result of hysterectomy or bilateral oophorectomy (surgical menopause).”
Designing poly-agonists for treatment of metabolic diseases: challenges and opportunities
Petersen, J., Strømgaard, K., Frølund, B., & Clemmensen, C. (2019) · Drugs · doi:10.1007/s40265-019-01153-6 · Cited by 17
Age-Related Trends in Body Composition among Women Aged 20–80 Years: A Cross-Sectional Study
Rathnayake, N., Rathnayake, H., & Lekamwasam, S. (2022) · Journal of Obesity · doi:10.1155/2022/4767793 · Cited by 17
“Reduction in energy expenditure due to reduced basal metabolic rate with age [36] and age-related reduced lipoprotein lipase activity [42] may partly explain the increase in TBFM with age.”
BackgroundThe beneficial roles and mechanisms of estrogens in immune health and infection disease
Chen, L., Xu, T., Lou, J., Zhang, T., Wu, S., Xu, J., & Xu, J. (2024) · Steroids · doi:10.1016/j.steroids.2024.109426 · Cited by 18
Sex Differences in Body Fat Distribution
Veilleux, A., & Tchernof, A. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0965-6_5 · Cited by 20
Schreiber, A. L., Arceneaux, K. P., Malbrue, R. A., Mouton, A. J., Chen, C. S., Bench, E. M., Braymer, H. D., & Primeaux, S. D. (2016) · Neuropeptides · doi:10.1016/j.npep.2016.01.004 · Cited by 17
“Though many of these comorbidities are prevalent in both males and females, obesity in females is associated with a higher rate of infertility, Type II Diabetes, cardiovascular disease, depression, and some forms of cancer (Guh et al., 2009; Hackethal et al., 2014; Yao et al., 2014).”
BackgroundInfluentialSymptoms and lung function decline in a middle-aged cohort of males and females in Australia
Abramson, M. J., Kaushik, S., Benke, G., Borg, B. M., Smith, C. L., Dharmage, S. C., & Thompson, B. (2016) · International Journal of COPD · doi:10.2147/copd.s103817 · Cited by 21
“It is well known that male pattern obesity (the so-called apple shape) and metabolic syndrome become more common in postmenopausal females.(30) Our female participants gained more weight and had a significantly greater increase in BMI than males.”
Jin, B., Chen, X., Xing, L., Xu, W., Fu, X., Zhu, J., Mou, X., Wang, Z., & Shu, J. (2017) · Climacteric · doi:10.1080/13697137.2017.1319920 · Cited by 17
“The mice were then either ovariectomized or sham-operated, and divided into three groups (n1⁄4 12 per group): (1) shamoperated, (2) ovariectomized (OVX), and (3) OVXþ E2 (17bestradiol) (Figure 1A).”
MethodIdentification of functional estrogen response elements in glycerol channel Aquaporin-7 gene
Xing, L., Jin, B., Fu, X., Zhu, J., Guo, X., Xu, W., Mou, X., Wang, Z., Jiang, F., Zhou, Y., et al. (2019) · Climacteric · doi:10.1080/13697137.2019.1580255 · Cited by 17
Sakamaki, K., Tsunekawa, K., Ishiyama, N., Kudo, M., Ando, K., Akuzawa, M., Nakajima, K., Shimomura, Y., Araki, O., Kimura, T., et al. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.10.022 · Cited by 19
Amiri, M., Karabegović, I., van Westing, A. C., Verkaar, A. J. C. F., Beigrezaei, S., Lara, M., Bramer, W. M., & Voortman, T. (2021) · Maturitas · doi:10.1016/j.maturitas.2021.10.001 · Cited by 22
Acharya, K. D., Friedline, R. H., Ward, D. V., Graham, M. E., TAUER, L. A., Zheng, D., Hu, X., de Vos, W. M., McCormick, B. A., Kim, J. K., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1010806 · Cited by 17
Harraqui, K., Oudghiri, D. E., Mrabti, H. N., Hannoun, Z., Lee, L., Assaggaf, H. M., Qasem, A. H., Goh, K. W., Ming, L. C., Tan, C. S., et al. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20031739 · Cited by 17
“Metabolic disorders, such as obesity, abdominal obesity, dyslipidemia, hypertension, type 2 diabetes, and impaired fasting glucose and insulin resistance, may constitute the components of the metabolic syndrome, and are most frequent during menopause [13,14].”
BackgroundGlucose Homeostasis, Diabetes Mellitus, and Gender-Affirming Treatment
Milionis, C., Ilias, Ι., Venaki, E., & Koukkou, E. G. (2023) · Biomedicines · doi:10.3390/biomedicines11030670 · Cited by 19
“On the other hand, insulin sensitivity diminishes in women after menopause [56].”
Impaired PI3 K Akt expression in liver and skeletal muscle of ovariectomized rats
Wang, Y., Li, B., Zhang, W., Liu, Y., Xue, P., Ma, J., & Li, Y. (2013) · Endocrine · doi:10.1007/s12020-013-9894-1 · Cited by 18
In female rat heart mitochondria, oophorectomy results in loss of oxidative phosphorylation
Pavón, N., Cabrera‐Orefice, A., Gallardo‐Pérez, J. C., Uribe‐Alvarez, C., Rivero-Segura, N. A., Vázquez-Martínez, E. R., Cerbón, M. A., Abundis, E. M., Torres-Narváez, J. C., Martínez‐Memije, R., et al. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0161 · Cited by 17
“2002, Carr 2003, Toth et al.”
Informal caregiving and metabolic markers in the UK Household Longitudinal Study
Lacey, R. E., McMunn, A., & Webb, E. A. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.01.002 · Cited by 18
Trujillo-Hernández, B., Trujillo-Magallón, E., Trujillo-Magallón, M., Brizuela-Araujo, C. A., García-Medina, M. A., González-Jiménez, M. A., López-Peña, G. A., Minakata-Nieto, J., Rincón-Gutiérrez, L. A., Tintos-Rueda, T., et al. (2017) · Revista de Salud Pública · doi:10.15446/rsap.v19n5.56960 · Cited by 17
Szkup, M., Chełmecka, E., Lubkowska, A., Owczarek, A. J., & Grochans, E. (2018) · Aging · doi:10.18632/aging.101600 · Cited by 18
“The risk of MetS has been noticed to significantly increase in the peri- and postmenopausal periods, irrespective of age and other commonly known risk factors for cardiovascular disease [20, 21].”
BackgroundMethodChen, J., Jia, Y., Liu, J., Liu, Y., Kai-Lin, J. I. A. O., Teng, M., Hu, C., Zhen, J., Wu, M., Zhou, M., et al. (2018) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(18)30125-0 · Cited by 17
Increased blood pressure variability in menopause.
Migneco, A., Ojetti, V., Covino, M., Mettimano, M., Montebelli, M. R., Leone, A., Specchia, L., Gasbarrini, A., & Savi, L. (2008) · PubMed · Cited by 21
Kim, S., Lee, J., Im, J., Kim, D., Lee, H. S., Kim, S.-H., & Lee, J. (2013) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31828838e8 · Cited by 17
“has been proposed.(17,18) Furthermore, hormonal and metabolic changes during menopause result in an increase in serum osteocalcin levels, and features of the cross-talk between serum osteocalcin and glucose metabolism in postmenopause may differ from those in premenopause.”
BackgroundZaman, G. S., & Zaman, F. (2015) · Journal of Natural Science Biology and Medicine · doi:10.4103/0976-9668.149098 · Cited by 16
“The increased cardiovascular disease (CVD) risk after menopause seems to be associated with the emergence of the features of metabolic syndrome.[6,7] In fact, women with type 2 diabetes mellitus (T2DM), compared with age-matched nondiabetic women, exhibit several-fold higher rates of death-related to coronary artery d…”
ResultŠabanović, Š., Majnarić, L. T., Babič, F., Vadovský, M., Paralič, J., Včev, A., & Holzinger, A. (2018) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-018-0601-2 · Cited by 17
“This predisposition may be due to the effect of both, hypertension and menopause, on abdominal fat accumulation [34, 72].”
BackgroundJang, H., Bae, J. H., Kim, M., Park, M. Y., Kim, H.-R., & Lee, Y. (2020) · Nutrients · doi:10.3390/nu12061631 · Cited by 17
Review of mendelian randomization studies on age at natural menopause
Zhang, X., Huangfu, Z., & Wang, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1234324 · Cited by 20
“In addition, estrogen de fi ciency can cause glucose intolerance and body fat redistribution, leading to increased central adiposity and increased IR (107, 108).”
BackgroundUmbayev, B. A., Saliev, T. M., Safarova, Y., Yermekova, A., Olzhayev, F., Bulanin, D. S., Tsoy, A., & Askarova, S. (2023) · Nutrients · doi:10.3390/nu15234964 · Cited by 16
“Changes occurring postmenopausal may heighten the risk of insulin resistance and the development of type 2 diabetes [100].”
BackgroundLee, H.-S., & Kwon, C.-S. (2010) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2010.39.4.511 · Cited by 16
“이처 럼 연령에 따른 대사증후군의 유병 양상에서 남녀가 다르게 나타나는 것은 남자는 50세 이전에 흡연, 음주, 불규칙한 식 사습관, 높은 스트레스와 함께 정적인 생활습관으로 인해 대사증후군 유병율이 높으며 여자는 50세 이상에서 나타나 는 폐경과 관련이 있을 것으로 보인다(18,19).”
Regulação da massa corpórea pelo estrogênio e pela atividade física
Ignacio, D. L., Frankenfeld, T. G. P., Fortunato, R. S., Vaisman, M., Werneck‐de‐Castro, J. P., & de Carvalho, D. P. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000300003 · Cited by 45
Severity of coronary artery disease in postmenopausal diabetic women
Saltiki, K., Cimponeriu, A., Lili, K., Peppa, Μ., Anastasiou, E., & Alevizaki, M. K. (2008) · HORMONES · doi:10.1007/bf03401506 · Cited by 22
Chu, M. C., Cushman, M., Solomon, R., & Løbo, R. A. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.04.033 · Cited by 16
Hirose, A., Terauchi, M., Hirano, M., Akiyoshi, M., Owa, Y., Kato, K., & Kubota, T. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.11.008 · Cited by 18
Majnarić, L. T., Martinović, I., Šabanović, Š., Rudan, S., Babič, F., & Wittlinger, T. (2019) · International Journal of Hypertension · doi:10.1155/2019/9848125 · Cited by 16
“An explanation for these results can be found in characteristics of the patient group that is highly vulnerable to MS, due to the synergistic interplay of hypertension, increased body weight, and menopause, all states where insulin resistance, a driving force of MS, is an underlying mechanism [13, 14, 38].”
BackgroundResultInfluentialPrimary Hypertriglyceridemia: A Look Back on the Clinical Classification and Genetics of the Disease
Musambil, M., Al-Rubeaan, K. A., Al-Qasim, S., Alnaqeb, D., & Al-Soghayer, A. (2020) · Current Diabetes Reviews · doi:10.2174/1573399815666190502164131 · Cited by 16
JUNG, U. S., JEONG, K. J., KANG, J. K., YI, K., SHIN, J.-H., SEO, H. S., KIM, T., KIM, S.-H., & HUR, J.-Y. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1440 · Cited by 15
Abelman, R. A., Ma, Y., Mehta, C. C., Yang, Q., Xia, F., Brock, J. B., Alcaide, M. L., Sharma, A., Floris-Moore, M., Topper, E., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae540 · Cited by 15
Xiao, E., Kim, A. J., Dutia, R., Conwell, I. M., Ferin, M., & Wardlaw, S. L. (2010) · Endocrinology · doi:10.1210/en.2009-0853 · Cited by 16
The effects of hormone therapy on metabolic risk factors in postmenopausal Korean women
Kim, S. M., Kim, S. H., Lee, J. R., Jee, B. C., Ku, S.-Y., Suh, C. S., Choi, Y., Kim, J. G., & Moon, S. Y. (2010) · Climacteric · doi:10.3109/13697137.2010.498593 · Cited by 17
Age- and Sex-Related Differential Associations between Body Composition and Diabetes Mellitus
Roh, E., Hwang, S. Y., Kim, J. A., Lee, Y., Hong, S., Kim, N. H., Seo, J. A., Kim, S. G., Kim, N. H., Choi, K. M., et al. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0171 · Cited by 16
“As a result, men have a relatively higher risk of cardiovascular diseases compared to that in age-matched women, whereas by age 70, the incidence of cardiovascular diseases is similar between sexes [15].”
BackgroundPredicting the age at natural menopause in middle-aged women
Hyvärinen, M., Karvanen, J., Aukee, P., Tammelin, T., Sipilä, S., Kujala, U. M., Kovanen, V., Rantalainen, T., & Laakkonen, E. K. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001774 · Cited by 17
Raman, V., Kose, V. D., Somalwar, S. A., Dwidmuthe, K. S., & Rao, S. (2023) · Cureus · doi:10.7759/cureus.39069 · Cited by 17
“Introduction And Background Metabolic syndrome (MetS) leads to various symptoms that include type II diabetes, central obesity, cardiovascular diseases (CVD), altered glucose metabolism, hypertension, and dyslipidemia which is caused due to complex metabolic dysregulation [1,2].”
BackgroundZhao, X., Lu, C., Song, B., Chen, D., Teng, D., Shan, Z., & Teng, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1290855 · Cited by 15
“In addition, the development of insulin resistance in older populations may play a role (54).”
BackgroundGawałek, M., & Sliwowska, J. H. (2015) · Reproductive Biology · doi:10.1016/j.repbio.2015.04.001 · Cited by 17
Lin, K., Tsay, S., Tsai, S., Kuo, S., & Chou, P. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31803bb22c · Cited by 16
Wakabayashi, I. (2012) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2012.07.001 · Cited by 19
“The above findings of gender-specific age-dependent increase in TG/HDL ratio in women agree with the fact that the risk for cardiovascular disease increases after menopause in women, although there is controversy whether menopause increases the risk of cardiovascular disease independent of normal aging (Carr, 2003).”
BackgroundInfluentialCorrelations Between White Blood Cell Count and Metabolic Syndrome in Middle-Age Taiwanese
Chuo, S.-K., Li, J.-C., Tsai, W., Wu, D., Kuo, S., Pei, D., Chen, S., & Shen, D. C. (2005) · Endocrine Research · doi:10.1080/07435800500229151 · Cited by 15
Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice
Ben-Shmuel, S., Scheinman, E. J., Rashed, R., Orr, Z. S., Gallagher, E. J., LeRoith, D., & Rostoker, R. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0310 · Cited by 17
“The prevalence of obesity markedly increases with the decline in estradiol levels following menopause (Carr 2003).”
BackgroundTeneligliptin improves metabolic abnormalities in a mouse model of postmenopausal obesity
Sameshima, A., Wada, T., Ito, T., Kashimura, A., Sawakawa, K., Yonezawa, R., Tsuneki, H., Ishii, Y., Sasahara, M., Saito, S., et al. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0239 · Cited by 16
“Cardiovascular disease, osteoporosis, and cognitive decline become more prevalent in menopause (Resnick et al. 1997, Carr 2003).”
BackgroundAoi, S., Miyake, T., Iida, T., Ikeda, H., Ishizaki, F., Chikamura, C., Tamura, N., Nitta, Y., Harada, T., & Miyaguchi, H. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.31963 · Cited by 16
Геннадиевна, С. М., Skalny, A. V., Serebryansky, E. P., Yurasov, V. V., Skalnaya, A. A., & Tinkov, A. A. (2017) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2017.09.008 · Cited by 16
Castillo, A., Zantut‐Wittmann, D. E., Neto, A. M., Jales, R. M., & Garmes, H. M. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0649-8010 · Cited by 17
“Probably the variations in the concentrations of the sex hormones are responsible for the differences between men and women [50, 51].”
BackgroundDoes gender influence the outcome of ischemic heart disease?
Tomaszewski, M., Topyła, W., Kijewski, B. G., Miotła, P., & Wacinski, P. J. (2019) · Menopause Review/Przegląd Menopauzalny · doi:10.5114/pm.2019.84158 · Cited by 21
“Hence, there is a higher incidence of cardiovascular disease in women who have experienced premature menopause, independent of other risk factors such as hypertension, obesity and smoking [13, 14].”
BackgroundThe resistant starch from sorghum regulates lipid metabolism in menopausal rats via equol
Ge, Y., Wei, C., Wang, W., & Cao, L. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13295 · Cited by 15
Barranco-Ruíz, Y., Villa‐González, E., Venegas‐Sanabria, L. C., Chavarro‐Carvajal, D. A., Cano, C. A., Izquierdo, M., Correa‐Bautista, J. E., González‐Ruíz, K., & Ramírez‐Vélez, R. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0066 · Cited by 16
“37 The cessation of estrogen secretion at the beginning of menopause accentuates these aspects, decreasing the quality of life.”
Body fat distribution in relation to smoking and exogenous hormones in British women
Kwok, S., Canoy, D., Soran, H., Ashton, D. W., Lowe, G. D. O., Wood, D., Humphries, S. E., & Durrington, P. N. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04331.x · Cited by 15
Zhang, H., Chen, X., & Sairam, M. R. (2011) · Diabetologia · doi:10.1007/s00125-011-2212-7 · Cited by 16
“Visceral obesity as a major risk factor for the metabolic syndrome is increased in postmenopausal women [1] and in sex hormone imbalance endocrine disorders such as hyperandrogenaemia in polycystic ovary syndrome [2].”
BackgroundChien, L.-W., Lin, M.-H., Chung, H., & Liu, C.-F. (2009) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/nep145 · Cited by 15
“Redistribution of body fat with increased visceral fat is believed to correlate with increased prevalence of metabolic syndrome, and consequently, cardiovascular disease in postmenopausal women [7, 8].”
BackgroundCarlo, C. D., Sardo, A. D. S., Bifulco, G., Tommaselli, G. A., Guerra, G., Rippa, E., Mandato, V. D., & Nappi, C. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.101 · Cited by 15
The Mediation of Hepatic Lipogenesis Through Estrogens
Miller, C. N., Della‐Fera, M. A., & Baile, C. A. (2013) · Postdoc Journal · doi:10.14304/surya.jpr.v1n5.4 · Cited by 17
“Carr MC. 2003.”
Lee, O., Kim, J., Lee, H., & Choue, R. (2012) · 대한지역사회영양학회지 · doi:10.5720/kjcn.2012.17.1.69 · Cited by 15
“폐경 후 여성에서 식사의 질 저하는 갱년기 증상의 심화와 더불어 삶의 질 저하를 야기 시키는 것으로 보고되고 있다 (Carr 2003).”
Nakaoka, K., Yamada, A., Noda, S., & Goseki‐Sone, M. (2018) · Nutrition Research · doi:10.1016/j.nutres.2018.03.001 · Cited by 17
Role of progestins with partial antiandrogenic effects
Sitruk-Ware, R. L., Husmann, F., Thijssen, J. H. H., Skouby, S. O., Fruzzetti, F., Hanker, J. P., Huber, J., & Druckmann, R. A. (2004) · Climacteric · doi:10.1080/13697130400001307 · Cited by 16
Meneyrol, K., Estévez‐Salguero, Á., González‐García, I., Guitton, J., Taouis, M., Benomar, Y., Magnan, C., López, M., & Stunff, H. L. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154846 · Cited by 15
Dileo, E., Saba, F., Parasiliti‐Caprino, M., Rosso, C., & Bugianesi, E. (2025) · Nutrients · doi:10.3390/nu17030477 · Cited by 14
“In women, estrogens prevent metabolic syndrome and the development of cardio-vascular diseases (CVD), while low levels of estrogens influence the onset of MASLD [22,23].”
MacDonald, T. L., Ritchie, K., Davies, S. C., Hamilton, M. J., Cervone, D. T., & Dyck, D. J. (2015) · Physiological Reports · doi:10.14814/phy2.12617 · Cited by 17
“The decline and eventual loss of circulating estrogen, specifically bioactive 17-b-estradiol (E2), is independently associated with increased risk for developing metabolic syndrome (reviewed by Carr 2003; Spangenburg et al. 2012b).”
BackgroundCheng, F., Yin, X. H., Duan, W., Ye, R., Zhu, Y., & Jia, C. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12863 · Cited by 14
“As females enter menopause, there is a decline in circulating estrogen.(37) Estrogen could improve body fat distribution, ameliorate insulin resistance, and promote β-cell function.”
BackgroundImpacts of Sex Differences in Pulse Pressure among Patients with Chronic Kidney Disease
Kataoka, H., Sawara, Y., Kawachi, K., Manabe, S., Mochizuki, T., & Nitta, K. (2019) · Journal of Personalized Medicine · doi:10.3390/jpm9040052 · Cited by 14
“However, menopause and the associated decline in estrogen levels are associated with an increase in the amount of visceral fat tissue and adipocyte hypertrophy [42]; consequently, features associated with metabolic syndrome generally emerge in postmenopausal women [43,44].”
BackgroundKim, G., Chun, H., & Doo, M. (2020) · Nutrients · doi:10.3390/nu12040945 · Cited by 17
“Studies have shown that extra weight and obesity in middle-aged women are related to body composition, which is a risk factor for metabolic syndrome [27,28].”
BackgroundAssociation between reproductive lifespan and lung function among postmenopausal women
Lim, J. H., Kang, D., Hong, Y. S., Kim, H., Ryu, S., Chang, Y., Park, H. Y., & Cho, J. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-19-3726 · Cited by 15
“Moreover, postmenopausal women become more insulin resistant (5,28), which is associated with lower lung function and increased respiratory symptoms (29-31).”
BackgroundAwareness and Related Factors of Dyslipidemia in Menopausal Women in Korea
Jeong, J. H., & Kim, M. (2022) · Healthcare · doi:10.3390/healthcare10010112 · Cited by 14
“Their low-density lipoprotein cholesterol (LDLC), total cholesterol (TC), and triglycerides (TG) increase and high-density lipoprotein cholesterol (HDL-C) decreases [4].”
BackgroundManaging Cardiovascular Risk in Patients with Rheumatic Disease
Ferguson, L. D., Sattar, N. A., & McInnes, I. B. (2022) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2022.02.003 · Cited by 14
Than, S., Moran, C., Collyer, T. A., Beare, R. J., Lane, E. M., Vincent, A. J., Wang, W., Callisaya, M. L., Thomson, R., Phan, T. G., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201028 · Cited by 13
Song, D. K., Hong, Y. S., Sung, Y., & Lee, H. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283393 · Cited by 17
“Menopausal status is associated with an increased risk for cardiovascular diseases mainly due to changes in body fat distribution, glucose metabolism, and serum lipids [2].”
BackgroundCao, Y., DiGiacomo, M. L., Du, H., Ollerton, E., & Davidson, P. M. (2008) · The Journal of Cardiovascular Nursing · doi:10.1097/01.jcn.0000317446.97951.c2 · Cited by 16
Park, J., Choi, M., Lee, S. H., Choi, Y., & Park, Y. K. (2011) · Journal of Nutrition and Health · doi:10.4163/kjn.2011.44.1.29 · Cited by 14
Radwan, M. M., Radwan, B. M., Nandipati, K. C., Hunter, W. J., & Agrawal, D. K. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2013.816484 · Cited by 16
[Cardiovascular disease as a current threat of older women. Relation to estrogens].
Zárate, A., Saucedo, R., Basurto, L., & Martínez, C. (2007) · PubMed · Cited by 14
Gender differences in metabolic syndrome risk factors among patients with serious mental illness
Tzeng, W., Chiang, Y., Feng, H., Chien, W., Tai, Y., & Chen, M. (2019) · International Journal of Mental Health Nursing · doi:10.1111/inm.12670 · Cited by 14
Merhi, Z. O. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4465 · Cited by 14
“The surgical removal of the ovaries or the natural loss of ovarian function gives rise to the menopause, a phase in a woman’s life that is characterized by increased risk for osteoporosis, cognitive dysfunction, diabetes, dyslipidemia, and CVD (3).”
BackgroundInfluential
Metadata
- Authors
- Carr, M. C.
- Affiliations
- University of Washington (US)
- Corresponding author
- Carr, Molly C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2404-2411
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2123609879
- Cited by
- 1,449
- References
- 84
- Citations by year
- 2026: 54 · 2025: 64 · 2024: 55 · 2023: 67 · 2022: 69 · 2021: 69 · 2020: 65 · 2019: 67 · 2018: 86 · 2017: 61 · 2016: 97 · 2015: 91 · 2014: 79 · 2013: 84 · 2012: 86
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- metabolic syndrome, menopause, estrogen deficiency, ovarian failure, abdominal obesity, insulin resistance, dyslipidemia, cardiovascular risk, postmenopausal women, atherogenic lipid profile, small dense LDL, glucose metabolism
- MeSH terms
- Body Composition, Cardiovascular Diseases, Female, Humans, Menopause, Risk Factors, Prevalence, Metabolic Syndrome, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.